25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Meta Biomed Co. Ltd
Buy, Hold or Sell?

Let's analyze Meta Biomed Co. Ltd together

I guess you are interested in Meta Biomed Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Meta Biomed Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Meta Biomed Co. Ltd

I send you an email if I find something interesting about Meta Biomed Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Meta Biomed Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Meta Biomed Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.01
When do you have the money?
1 year
How often do you get paid?
85.0%

What is your share worth?

Current worth
₩3,514.95
Expected worth in 1 year
₩4,251.60
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
₩756.12
Return On Investment
20.6%

For what price can you sell your share?

Current Price per Share
₩3,665.00
Expected price per share
₩2,468 - ₩3,805
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Meta Biomed Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩3,665.00

2.2. Growth of Meta Biomed Co. Ltd (5 min.)




Is Meta Biomed Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$57.8m$44.2m$9.1m17.1%

How much money is Meta Biomed Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.5m$650k$1.9m74.9%
Net Profit Margin16.3%4.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Meta Biomed Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Meta Biomed Co. Ltd?

Welcome investor! Meta Biomed Co. Ltd's management wants to use your money to grow the business. In return you get a share of Meta Biomed Co. Ltd.

First you should know what it really means to hold a share of Meta Biomed Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Meta Biomed Co. Ltd is ₩3,665. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Meta Biomed Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Meta Biomed Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩3,514.95. Based on the TTM, the Book Value Change Per Share is ₩184.16 per quarter. Based on the YOY, the Book Value Change Per Share is ₩31.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩4.87 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Meta Biomed Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.120.0%0.110.0%0.030.0%0.040.0%0.020.0%
Usd Book Value Change Per Share0.130.0%0.130.0%0.020.0%0.040.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.130.0%0.130.0%0.040.0%0.050.0%0.040.0%
Usd Price Per Share3.38-3.05-2.02-2.14-2.53-
Price to Earnings Ratio7.18-7.95--4.54-3.29-14.35-
Price-to-Total Gains Ratio26.74-34.55-30.34-14.73-68.40-
Price to Book Ratio1.37-1.34-1.07-1.19-1.55-
Price-to-Total Gains Ratio26.74-34.55-30.34-14.73-68.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.5655
Number of shares389
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.130.04
Usd Total Gains Per Share0.130.05
Gains per Quarter (389 shares)51.4720.83
Gains per Year (389 shares)205.8983.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15201196137073
21140140227140156
31660260840210239
42180281453280322
5271003102066350405
6321204122680420488
7371404143293490571
84216051638106560654
94818051844120630737
105320062050133700820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%25.09.06.062.5%30.09.07.065.2%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%28.012.00.070.0%32.014.00.069.6%
Dividend per Share1.00.03.025.0%9.00.03.075.0%17.00.03.085.0%34.00.06.085.0%37.00.09.080.4%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%29.011.00.072.5%33.013.00.071.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Meta Biomed Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--180.661184.163-2%31.323+477%64.272+181%40.722+344%
Book Value Per Share--3514.9523245.153+8%2691.213+31%2554.869+38%2367.054+48%
Current Ratio--1.1291.204-6%1.151-2%1.1330%0.741+52%
Debt To Asset Ratio--0.5080.480+6%0.493+3%0.499+2%0.525-3%
Debt To Equity Ratio--1.0670.968+10%0.975+10%1.011+6%1.144-7%
Dividend Per Share---4.868-100%19.484-100%12.208-100%9.820-100%
Enterprise Value--28168016000.00030697108927.500-8%25020152552.500+13%26593802441.000+6%30662199855.500-8%
Eps--168.068157.515+7%39.532+325%52.991+217%29.937+461%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%nannan%
Ev To Sales Ratio--0.2780.346-20%0.321-13%0.391-29%infnan%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.825+21%
Market Cap86099646000.000-32%113468292000.000102368133000.000+11%67775574000.000+67%71963094300.000+58%84977266050.000+34%
Net Profit Margin--0.1560.163-5%0.043+265%0.072+117%0.043+267%
Operating Margin----0%0.021-100%0.046-100%0.024-100%
Operating Ratio--1.0941.323-17%1.085+1%0.858+27%0.902+21%
Pb Ratio1.043-32%1.3741.343+2%1.066+29%1.194+15%1.552-11%
Pe Ratio5.452-32%7.1857.947-10%-4.541+163%3.289+118%14.349-50%
Price Per Share3665.000-32%4830.0004357.500+11%2885.000+67%3063.250+58%3617.000+34%
Price To Free Cash Flow Ratio---7.816-100%-13.4690%-5.1460%-3.4480%
Price To Total Gains Ratio20.287-32%26.73534.549-23%30.340-12%14.732+81%68.396-61%
Quick Ratio---0.419-100%0.917-100%0.785-100%0.536-100%
Return On Assets--0.0240.024-4%0.007+219%0.014+63%0.008+192%
Return On Equity--0.0490.050-1%0.014+249%0.028+79%0.015+223%
Total Gains Per Share--180.661189.031-4%50.807+256%76.479+136%50.543+257%
Usd Book Value--57802253.60053365503.861+8%44256142.940+31%42014007.936+38%38927722.788+48%
Usd Book Value Change Per Share--0.1260.129-2%0.022+477%0.045+181%0.029+344%
Usd Book Value Per Share--2.4602.272+8%1.884+31%1.788+38%1.657+48%
Usd Dividend Per Share---0.003-100%0.014-100%0.009-100%0.007-100%
Usd Enterprise Value--19717611.20021487976.249-8%17514106.787+13%18615661.709+6%21463539.899-8%
Usd Eps--0.1180.110+7%0.028+325%0.037+217%0.021+461%
Usd Free Cash Flow---156225.823-100%-1779091.0150%-451810.0500%-714421.9230%
Usd Market Cap60269752.200-32%79427804.40071657693.100+11%47442901.800+67%50374166.010+58%59484086.235+34%
Usd Price Per Share2.566-32%3.3813.050+11%2.020+67%2.144+58%2.532+34%
Usd Profit--2763832.4002590283.014+7%650083.642+325%1254827.533+120%691719.740+300%
Usd Revenue--17728960.20015765877.782+12%13605791.260+30%13140070.634+35%12007394.519+48%
Usd Total Gains Per Share--0.1260.132-4%0.036+256%0.054+136%0.035+257%
 EOD+3 -4MRQTTM+13 -20YOY+19 -135Y+20 -1210Y+23 -9

3.3 Fundamental Score

Let's check the fundamental score of Meta Biomed Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.452
Price to Book Ratio (EOD)Between0-11.043
Net Profit Margin (MRQ)Greater than00.156
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.129
Debt to Asset Ratio (MRQ)Less than10.508
Debt to Equity Ratio (MRQ)Less than11.067
Return on Equity (MRQ)Greater than0.150.049
Return on Assets (MRQ)Greater than0.050.024
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Meta Biomed Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.478
Ma 20Greater thanMa 503,575.250
Ma 50Greater thanMa 1003,799.100
Ma 100Greater thanMa 2003,965.050
OpenGreater thanClose3,580.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Meta Biomed Co. Ltd

Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone products consisting of bone graft substitutes and cement; and cosmetic medical products, as well as ultrasonic imaging diagnosis devices. The company was formerly known as Metadental Co., Ltd. and changed its name to Meta Biomed Co., Ltd. in 2001. Meta Biomed Co., Ltd. was founded in 1990 and is headquartered in Cheongju, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 19:05:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Meta Biomed Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • A Net Profit Margin of 15.6% means that ₩0.16 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Meta Biomed Co. Ltd:

  • The MRQ is 15.6%. The company is making a huge profit. +2
  • The TTM is 16.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.6%TTM16.3%-0.7%
TTM16.3%YOY4.3%+12.1%
TTM16.3%5Y7.2%+9.1%
5Y7.2%10Y4.3%+2.9%
4.3.1.2. Return on Assets

Shows how efficient Meta Biomed Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • 2.4% Return on Assets means that Meta Biomed Co. Ltd generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Meta Biomed Co. Ltd:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%-0.1%
TTM2.4%YOY0.7%+1.7%
TTM2.4%5Y1.4%+1.0%
5Y1.4%10Y0.8%+0.6%
4.3.1.3. Return on Equity

Shows how efficient Meta Biomed Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • 4.9% Return on Equity means Meta Biomed Co. Ltd generated ₩0.05 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Meta Biomed Co. Ltd:

  • The MRQ is 4.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 5.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM5.0%0.0%
TTM5.0%YOY1.4%+3.6%
TTM5.0%5Y2.8%+2.2%
5Y2.8%10Y1.5%+1.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Meta Biomed Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Meta Biomed Co. Ltd is operating .

  • Measures how much profit Meta Biomed Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Meta Biomed Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.1%-2.1%
TTM-5Y4.6%-4.6%
5Y4.6%10Y2.4%+2.2%
4.3.2.2. Operating Ratio

Measures how efficient Meta Biomed Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are ₩1.09 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 1.094. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.323. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.094TTM1.323-0.229
TTM1.323YOY1.085+0.238
TTM1.3235Y0.858+0.465
5Y0.85810Y0.902-0.044
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Meta Biomed Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Meta Biomed Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • A Current Ratio of 1.13 means the company has ₩1.13 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 1.129. The company is just able to pay all its short-term debts.
  • The TTM is 1.204. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.129TTM1.204-0.075
TTM1.204YOY1.151+0.053
TTM1.2045Y1.133+0.071
5Y1.13310Y0.741+0.392
4.4.3.2. Quick Ratio

Measures if Meta Biomed Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.419-0.419
TTM0.419YOY0.917-0.498
TTM0.4195Y0.785-0.367
5Y0.78510Y0.536+0.250
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Meta Biomed Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Meta Biomed Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Meta Biomed Co. Ltd to Healthcare Equipment & Supplies industry mean.
  • A Debt to Asset Ratio of 0.51 means that Meta Biomed Co. Ltd assets are financed with 50.8% credit (debt) and the remaining percentage (100% - 50.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 0.508. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.480. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.508TTM0.480+0.028
TTM0.480YOY0.493-0.013
TTM0.4805Y0.499-0.019
5Y0.49910Y0.525-0.026
4.5.4.2. Debt to Equity Ratio

Measures if Meta Biomed Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • A Debt to Equity ratio of 106.7% means that company has ₩1.07 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 1.067. The company is able to pay all its debts with equity. +1
  • The TTM is 0.968. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.067TTM0.968+0.100
TTM0.968YOY0.975-0.007
TTM0.9685Y1.011-0.044
5Y1.01110Y1.144-0.133
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Meta Biomed Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Meta Biomed Co. Ltd to the Healthcare Equipment & Supplies industry mean.
  • A PE ratio of 7.18 means the investor is paying ₩7.18 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Meta Biomed Co. Ltd:

  • The EOD is 5.452. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.185. Based on the earnings, the company is cheap. +2
  • The TTM is 7.947. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.452MRQ7.185-1.733
MRQ7.185TTM7.947-0.762
TTM7.947YOY-4.541+12.488
TTM7.9475Y3.289+4.657
5Y3.28910Y14.349-11.060
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Meta Biomed Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.816-7.816
TTM7.816YOY-13.469+21.285
TTM7.8165Y-5.146+12.961
5Y-5.14610Y-3.448-1.698
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Meta Biomed Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Healthcare Equipment & Supplies industry mean).
  • A PB ratio of 1.37 means the investor is paying ₩1.37 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Meta Biomed Co. Ltd:

  • The EOD is 1.043. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.374. Based on the equity, the company is underpriced. +1
  • The TTM is 1.343. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.043MRQ1.374-0.331
MRQ1.374TTM1.343+0.031
TTM1.343YOY1.066+0.277
TTM1.3435Y1.194+0.149
5Y1.19410Y1.552-0.357
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Net Interest Income  -1,016,421500,522-515,89965,240-450,660-65,630-516,2891,424,428908,139



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets167,874,924
Total Liabilities85,300,276
Total Stockholder Equity79,915,994
 As reported
Total Liabilities 85,300,276
Total Stockholder Equity+ 79,915,994
Total Assets = 167,874,924

Assets

Total Assets167,874,924
Total Current Assets81,002,804
Long-term Assets86,872,119
Total Current Assets
Total Current Assets  (as reported)81,002,804
Total Current Assets  (calculated)0
+/- 81,002,804
Long-term Assets
Long-term Assets  (as reported)86,872,119
Long-term Assets  (calculated)0
+/- 86,872,119

Liabilities & Shareholders' Equity

Total Current Liabilities71,736,106
Long-term Liabilities13,564,170
Total Stockholder Equity79,915,994
Total Current Liabilities
Total Current Liabilities  (as reported)71,736,106
Total Current Liabilities  (calculated)0
+/- 71,736,106
Long-term Liabilities
Long-term Liabilities  (as reported)13,564,170
Long-term Liabilities  (calculated)0
+/- 13,564,170
Total Stockholder Equity
Total Stockholder Equity (as reported)79,915,994
Total Stockholder Equity (calculated)0
+/- 79,915,994
Other
Common Stock Shares Outstanding 22,871
Net Invested Capital 79,915,994
Net Working Capital 9,266,698



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
105,460,041
106,487,277
118,092,792
116,787,858
113,401,878
111,291,813
113,722,336
115,055,910
113,028,513
120,032,158
112,992,720
113,783,500
118,439,561
117,888,717
119,241,415
120,076,739
117,628,089
119,036,302
121,586,178
119,664,761
118,303,468
125,297,814
103,600,896
97,693,208
99,823,555
102,362,046
103,539,482
103,291,753
107,197,657
105,998,204
109,410,750
107,855,912
108,912,532
111,675,270
112,300,350
103,128,127
111,552,840
118,968,963
125,976,776
121,072,391
124,631,464
127,511,545
129,855,533
130,124,258
163,775,118
167,874,924
167,874,924163,775,118130,124,258129,855,533127,511,545124,631,464121,072,391125,976,776118,968,963111,552,840103,128,127112,300,350111,675,270108,912,532107,855,912109,410,750105,998,204107,197,657103,291,753103,539,482102,362,04699,823,55597,693,208103,600,896125,297,814118,303,468119,664,761121,586,178119,036,302117,628,089120,076,739119,241,415117,888,717118,439,561113,783,500112,992,720120,032,158113,028,513115,055,910113,722,336111,291,813113,401,878116,787,858118,092,792106,487,277105,460,041
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,771,546
36,044,762
37,367,427
42,874,406
44,085,507
40,275,974
40,329,965
41,459,489
41,845,846
40,799,929
43,971,407
46,428,196
50,370,715
52,122,583
53,392,601
57,100,786
57,993,523
45,660,650
53,806,568
52,757,504
57,576,843
50,975,808
51,179,768
53,043,295
52,459,892
49,923,649
76,881,689
81,002,804
81,002,80476,881,68949,923,64952,459,89253,043,29551,179,76850,975,80857,576,84352,757,50453,806,56845,660,65057,993,52357,100,78653,392,60152,122,58350,370,71546,428,19643,971,40740,799,92941,845,84641,459,48940,329,96540,275,97444,085,50742,874,40637,367,42736,044,76239,771,546000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,644,223
5,472,769
4,905,732
9,479,744
13,883,876
5,487,963
5,832,024
5,021,582
4,540,307
2,350,437
5,969,285
6,110,045
7,929,154
8,638,910
7,519,068
9,008,487
11,968,459
10,113,001
0
0
0
13,226,148
9,446,226
9,542,396
10,581,976
10,796,260
13,686,833
0
013,686,83310,796,26010,581,9769,542,3969,446,22613,226,14800010,113,00111,968,4599,008,4877,519,0688,638,9107,929,1546,110,0455,969,2852,350,4374,540,3075,021,5825,832,0245,487,96313,883,8769,479,7444,905,7325,472,7696,644,223000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
569,011
707,945
763,380
537,734
455,707
523,530
393,801
217,665
600,543
0
0
0
11,210,959
12,405,469
13,037,627
14,826,183
14,844,212
5,803,205
11,839,032
8,392,252
8,758,805
5,914,729
7,492,723
8,604,088
7,396,652
6,013,591
29,323,152
0
029,323,1526,013,5917,396,6528,604,0887,492,7235,914,7298,758,8058,392,25211,839,0325,803,20514,844,21214,826,18313,037,62712,405,46911,210,959000600,543217,665393,801523,530455,707537,734763,380707,945569,011000000000000000000
       Net Receivables 
13,114,507
13,183,623
13,025,674
12,943,946
14,085,431
11,942,364
12,685,609
15,724,544
15,110,535
14,979,417
13,710,269
12,325,879
13,746,014
14,691,201
12,626,177
13,786,795
11,497,704
10,777,432
11,622,862
12,570,560
13,342,470
14,681,318
12,540,683
14,309,465
15,120,830
16,970,271
14,407,211
15,860,655
13,562,017
13,362,554
12,855,619
12,128,982
13,396,443
15,169,918
13,266,451
13,046,041
13,602,645
15,161,516
17,909,377
12,896,231
17,266,904
15,436,936
14,047,152
12,880,409
13,089,480
0
013,089,48012,880,40914,047,15215,436,93617,266,90412,896,23117,909,37715,161,51613,602,64513,046,04113,266,45115,169,91813,396,44312,128,98212,855,61913,362,55413,562,01715,860,65514,407,21116,970,27115,120,83014,309,46512,540,68314,681,31813,342,47012,570,56011,622,86210,777,43211,497,70413,786,79512,626,17714,691,20113,746,01412,325,87913,710,26914,979,41715,110,53515,724,54412,685,60911,942,36414,085,43112,943,94613,025,67413,183,62313,114,507
       Other Current Assets 
5,268,987
2,005,569
2,820,107
1,201,114
1,953,565
970,147
1,985,653
6,114,571
1,234,914
1,271,965
1,526,063
1,977,607
4,305,767
1,617,527
3,022,063
8,629,436
10,044,563
9,532,788
9,925,834
10,171,161
3,409,700
2,858,883
1,398,593
1,006,533
958,054
1,138,705
350,798
1,292,329
2,091,468
2,426,298
1,855,011
1,672,604
1,401,243
1,388,939
1,541,484
1,203,196
1,232,497
1,808,176
2,115,305
314,754
305,519
325,678
191,788
159,387
114,228
0
0114,228159,387191,788325,678305,519314,7542,115,3051,808,1761,232,4971,203,1961,541,4841,388,9391,401,2431,672,6041,855,0112,426,2982,091,4681,292,329350,7981,138,705958,0541,006,5331,398,5932,858,8833,409,70010,171,1619,925,8349,532,78810,044,5638,629,4363,022,0631,617,5274,305,7671,977,6071,526,0631,271,9651,234,9146,114,5711,985,653970,1471,953,5651,201,1142,820,1072,005,5695,268,987
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,096,584
73,451,696
74,468,250
77,395,641
80,200,608
86,893,429
86,872,119
86,872,11986,893,42980,200,60877,395,64174,468,25073,451,69670,096,584000000000000000000000000000000000000000
       Property Plant Equipment 
50,084,313
50,549,060
50,478,891
51,602,573
51,784,234
51,474,373
51,648,413
52,376,192
52,323,057
53,024,845
54,058,017
52,943,745
51,948,962
51,737,182
51,003,068
46,415,444
45,864,383
43,571,621
44,622,355
48,039,631
52,075,944
39,356,967
40,610,161
40,561,907
42,244,097
43,274,107
44,312,206
45,591,490
46,063,626
44,737,300
43,917,093
42,726,158
42,425,278
39,506,058
39,546,431
39,277,524
39,494,241
43,702,863
47,297,695
52,123,203
54,919,690
56,250,273
57,568,784
59,086,434
64,986,294
0
064,986,29459,086,43457,568,78456,250,27354,919,69052,123,20347,297,69543,702,86339,494,24139,277,52439,546,43139,506,05842,425,27842,726,15843,917,09344,737,30046,063,62645,591,49044,312,20643,274,10742,244,09740,561,90740,610,16139,356,96752,075,94448,039,63144,622,35543,571,62145,864,38346,415,44451,003,06851,737,18251,948,96252,943,74554,058,01753,024,84552,323,05752,376,19251,648,41351,474,37351,784,23451,602,57350,478,89150,549,06050,084,313
       Goodwill 
0
0
0
629,711
0
0
0
872,486
0
0
0
872,486
0
0
0
524,062
0
0
0
524,062
524,062
0
0
524,062
524,062
0
0
524,062
524,062
0
0
524,062
0
0
0
524,062
0
0
0
2,023,399
0
0
0
1,008,498
0
0
001,008,4980002,023,399000524,062000524,06200524,062524,06200524,062524,06200524,062524,062000524,062000872,486000872,486000629,711000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,905,526
4,848,635
5,427,701
5,385,308
5,398,099
5,573,807
5,932,895
5,960,739
5,678,765
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000005,678,7655,960,7395,932,8955,573,8075,398,0995,385,3085,427,7014,848,6354,905,526000000000000000000
       Intangible Assets 
9,423,332
9,986,262
10,298,792
1,594,551
10,009,369
10,740,160
11,410,016
1,830,134
7,796,692
8,013,426
8,136,676
1,790,314
9,222,425
9,430,673
9,500,445
1,392,838
8,949,205
9,073,264
9,286,029
1,449,348
1,535,002
6,570,168
6,707,972
799,564
797,999
6,471,948
6,622,675
6,382,880
6,477,785
4,440,152
4,524,331
1,945,594
2,419,759
1,769,123
1,723,299
854,155
1,352,690
3,425,478
3,392,841
688,405
2,707,804
2,670,483
2,633,643
675,569
1,682,558
0
01,682,558675,5692,633,6432,670,4832,707,804688,4053,392,8413,425,4781,352,690854,1551,723,2991,769,1232,419,7591,945,5944,524,3314,440,1526,477,7856,382,8806,622,6756,471,948797,999799,5646,707,9726,570,1681,535,0021,449,3489,286,0299,073,2648,949,2051,392,8389,500,4459,430,6739,222,4251,790,3148,136,6768,013,4267,796,6921,830,13411,410,01610,740,16010,009,3691,594,55110,298,7929,986,2629,423,332
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-175,930
-301,961
-292,436
1
-1
0
0
00-11-292,436-301,961-175,930000000000000000000000000000000000000000
> Total Liabilities 
64,346,897
63,652,593
73,003,112
72,249,356
68,798,970
66,983,890
69,358,430
70,852,757
67,818,867
68,683,146
60,356,716
61,782,498
66,278,783
63,950,432
64,606,827
67,249,556
65,496,272
66,779,580
67,208,271
72,388,060
69,074,437
69,969,483
48,032,826
46,385,554
48,958,952
49,985,363
51,795,023
50,024,460
54,900,256
55,932,354
58,760,177
59,877,802
59,308,281
58,829,620
57,891,534
44,804,871
52,501,771
56,643,446
63,269,671
60,481,402
60,306,230
62,242,627
58,476,821
57,462,376
85,444,623
85,300,276
85,300,27685,444,62357,462,37658,476,82162,242,62760,306,23060,481,40263,269,67156,643,44652,501,77144,804,87157,891,53458,829,62059,308,28159,877,80258,760,17755,932,35454,900,25650,024,46051,795,02349,985,36348,958,95246,385,55448,032,82669,969,48369,074,43772,388,06067,208,27166,779,58065,496,27267,249,55664,606,82763,950,43266,278,78361,782,49860,356,71668,683,14667,818,86770,852,75769,358,43066,983,89068,798,97072,249,35673,003,11263,652,59364,346,897
   > Total Current Liabilities 
44,416,968
44,449,085
47,122,897
53,314,955
49,373,466
35,222,486
34,567,477
45,269,319
42,135,101
60,552,031
52,114,208
52,217,967
56,330,097
53,988,573
54,792,900
56,900,417
52,454,744
53,277,920
53,659,291
55,533,341
53,599,980
56,538,212
34,517,869
40,747,789
43,382,470
43,675,943
43,981,000
39,343,039
43,133,518
44,176,562
45,791,982
47,410,258
48,172,233
48,017,696
47,518,288
38,161,170
45,866,890
47,951,706
49,005,818
44,817,324
44,763,767
46,129,481
45,165,858
44,471,257
54,756,128
71,736,106
71,736,10654,756,12844,471,25745,165,85846,129,48144,763,76744,817,32449,005,81847,951,70645,866,89038,161,17047,518,28848,017,69648,172,23347,410,25845,791,98244,176,56243,133,51839,343,03943,981,00043,675,94343,382,47040,747,78934,517,86956,538,21253,599,98055,533,34153,659,29153,277,92052,454,74456,900,41754,792,90053,988,57356,330,09752,217,96752,114,20860,552,03142,135,10145,269,31934,567,47735,222,48649,373,46653,314,95547,122,89744,449,08544,416,968
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,981,696
1,858,549
789,601
2,428,947
2,320,175
1,551,683
1,394,237
111,938
33,453,934
30,098,078
34,523,708
37,454,491
37,759,579
38,717,680
40,266,098
38,431,466
38,275,164
24,829,552
30,595,485
31,762,704
31,553,194
31,230,000
33,591,590
33,579,160
0
0
0
0
000033,579,16033,591,59031,230,00031,553,19431,762,70430,595,48524,829,55238,275,16438,431,46640,266,09838,717,68037,759,57937,454,49134,523,70830,098,07833,453,934111,9381,394,2371,551,6832,320,1752,428,947789,6011,858,5491,981,696000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,981,696
1,858,549
789,601
2,428,947
2,320,175
1,551,683
1,394,237
111,938
96,946
0
0
0
0
0
0
0
0
0
0
0
0
32,178,680
34,395,223
34,362,246
32,925,905
31,699,027
34,541,070
0
034,541,07031,699,02732,925,90534,362,24634,395,22332,178,68000000000000096,946111,9381,394,2371,551,6832,320,1752,428,947789,6011,858,5491,981,696000000000000000000
       Accounts payable 
5,518,807
6,451,260
6,162,189
5,711,455
7,514,416
6,606,390
6,315,565
7,187,532
7,499,723
7,836,196
6,418,752
5,901,238
5,187,629
6,191,883
6,513,770
6,781,883
5,181,459
6,343,022
6,055,184
4,197,917
4,444,214
3,783,765
4,865,343
2,843,161
3,832,461
4,759,193
3,730,788
3,466,084
2,845,752
1,693,501
1,958,888
2,560,930
2,019,033
2,335,025
1,847,009
1,921,838
2,204,467
2,854,548
4,511,076
2,425,272
2,520,532
2,551,860
2,638,601
2,922,932
2,748,516
0
02,748,5162,922,9322,638,6012,551,8602,520,5322,425,2724,511,0762,854,5482,204,4671,921,8381,847,0092,335,0252,019,0332,560,9301,958,8881,693,5012,845,7523,466,0843,730,7884,759,1933,832,4612,843,1614,865,3433,783,7654,444,2144,197,9176,055,1846,343,0225,181,4596,781,8836,513,7706,191,8835,187,6295,901,2386,418,7527,836,1967,499,7237,187,5326,315,5656,606,3907,514,4165,711,4556,162,1896,451,2605,518,807
       Other Current Liabilities 
4,286,319
2,794,845
3,642,268
3,990,668
3,566,069
3,259,523
3,484,399
5,909,662
6,057,752
6,847,400
3,949,117
4,942,849
6,899,796
4,889,918
5,788,260
5,988,660
6,189,244
5,548,301
5,719,125
6,828,873
5,768,700
25,050,713
2,936,188
3,829,533
5,292,448
5,140,031
5,560,568
4,457,982
4,538,505
3,754,988
4,069,578
3,887,977
3,642,373
3,861,425
4,078,412
4,568,677
6,876,243
8,447,392
8,234,065
1
1
0
0
1
-2
0
0-2100118,234,0658,447,3926,876,2434,568,6774,078,4123,861,4253,642,3733,887,9774,069,5783,754,9884,538,5054,457,9825,560,5685,140,0315,292,4483,829,5332,936,18825,050,7135,768,7006,828,8735,719,1255,548,3016,189,2445,988,6605,788,2604,889,9186,899,7964,942,8493,949,1176,847,4006,057,7525,909,6623,484,3993,259,5233,566,0693,990,6683,642,2682,794,8454,286,319
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,815,798
12,833,441
13,282,763
13,310,963
12,991,118
30,688,496
13,564,170
13,564,17030,688,49612,991,11813,310,96313,282,76312,833,44112,815,798000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,689,525
8,021,290
8,860,950
9,351,868
10,578,383
9,837,369
8,428,176
8,027,949
7,251,184
3,929,268
3,685,194
4,071,790
5,534,551
11,747,132
12,387,376
12,913,779
0
0
0
0
000012,913,77912,387,37611,747,1325,534,5514,071,7903,685,1943,929,2687,251,1848,027,9498,428,1769,837,36910,578,3839,351,8688,860,9508,021,2904,689,52500000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,981,696
-1,858,549
-789,601
-2,428,947
-2,320,175
-1,551,683
-1,394,237
-111,938
-33,453,934
-30,098,078
-34,523,708
-37,454,491
-37,759,579
-38,717,680
-40,266,098
-38,431,466
-38,275,164
-24,829,552
-30,595,485
-31,762,704
-31,553,194
-30,955,436
-33,359,370
-33,357,527
287,289
541,484
503,914
0
0503,914541,484287,289-33,357,527-33,359,370-30,955,436-31,553,194-31,762,704-30,595,485-24,829,552-38,275,164-38,431,466-40,266,098-38,717,680-37,759,579-37,454,491-34,523,708-30,098,078-33,453,934-111,938-1,394,237-1,551,683-2,320,175-2,428,947-789,601-1,858,549-1,981,696000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
1
0
0
0010-100000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,690,574
4,845,087
0
0
5,310,269
5,313,701
0
0
5,611,983
5,704,922
0
0
1,184,873
0
0
0
70,898
0
0
0
0
0
0
0
0
0
0
000000000070,8980001,184,873005,704,9225,611,983005,313,7015,310,269004,845,0874,690,5740000000000000000000
> Total Stockholder Equity
40,058,442
41,716,543
44,032,164
43,489,598
43,535,854
43,291,294
43,171,358
42,943,888
43,743,107
50,242,283
51,397,424
50,870,179
51,033,012
52,826,108
53,550,407
51,590,684
50,954,684
51,017,853
53,077,283
46,011,498
47,965,562
53,932,243
54,180,153
49,969,919
49,558,375
50,955,547
51,744,458
53,267,293
52,297,401
50,065,850
50,650,573
47,978,110
49,604,251
52,845,650
54,408,816
58,323,256
59,051,069
62,325,517
62,707,105
60,590,989
64,325,234
65,268,918
68,517,353
70,047,571
75,675,134
79,915,994
79,915,99475,675,13470,047,57168,517,35365,268,91864,325,23460,590,98962,707,10562,325,51759,051,06958,323,25654,408,81652,845,65049,604,25147,978,11050,650,57350,065,85052,297,40153,267,29351,744,45850,955,54749,558,37549,969,91954,180,15353,932,24347,965,56246,011,49853,077,28351,017,85350,954,68451,590,68453,550,40752,826,10851,033,01250,870,17951,397,42450,242,28343,743,10742,943,88843,171,35843,291,29443,535,85443,489,59844,032,16441,716,54340,058,442
   Common Stock
8,550,178
8,550,178
8,550,178
8,550,178
8,550,178
8,754,260
8,754,260
9,468,545
9,468,545
10,657,678
10,759,718
10,759,718
10,759,718
10,937,212
10,937,212
10,937,212
10,937,212
10,937,212
10,937,212
10,937,212
10,954,961
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
11,931,176
0
0
0
0
000011,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17611,931,17610,954,96110,937,21210,937,21210,937,21210,937,21210,937,21210,937,21210,937,21210,759,71810,759,71810,759,71810,657,6789,468,5459,468,5458,754,2608,754,2608,550,1788,550,1788,550,1788,550,1788,550,178
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
34,490,703
0
0
0
0
000034,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70334,490,70300000000000000000000000000
   Treasury Stock0000000000-2,778,324-2,778,324-2,778,324-2,778,324-2,778,324-2,778,324-2,778,324-2,778,324-2,110,995-2,110,995000-1,483,075-1,483,075-1,483,075-1,483,075-1,483,075-1,483,075-1,483,075-1,323,199-756,600-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,098-498,097-498,098
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285,492
-341,033
-218,179
143,447
-190,837
-123,689
138,905
203,597
820,112
192,836
646,197
546,962
246,786
-102,905
277,583
362,742
957,128
1,075,390
1,335,955
1,745,504
2,634,571
1,202,074
1,454,395
1,417,513
0
0
0
0
00001,417,5131,454,3951,202,0742,634,5711,745,5041,335,9551,075,390957,128362,742277,583-102,905246,786546,962646,197192,836820,112203,597138,905-123,689-190,837143,447-218,179-341,033285,492000000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue83,100,722
Cost of Revenue-45,110,499
Gross Profit37,990,22337,990,223
 
Operating Income (+$)
Gross Profit37,990,223
Operating Expense-72,353,095
Operating Income10,747,626-34,362,873
 
Operating Expense (+$)
Research Development4,538,197
Selling General Administrative10,355,230
Selling And Marketing Expenses0
Operating Expense72,353,09514,893,428
 
Net Interest Income (+$)
Interest Income375,033
Interest Expense-2,315,059
Other Finance Cost-0
Net Interest Income-1,940,027
 
Pretax Income (+$)
Operating Income10,747,626
Net Interest Income-1,940,027
Other Non-Operating Income Expenses0
Income Before Tax (EBT)7,804,85110,747,626
EBIT - interestExpense = -2,315,059
10,080,410
12,395,469
Interest Expense2,315,059
Earnings Before Interest and Taxes (EBIT)010,119,910
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax7,804,851
Tax Provision--2,222,548
Net Income From Continuing Ops10,027,39910,027,399
Net Income10,080,410
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,940,027
 

Technical Analysis of Meta Biomed Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Meta Biomed Co. Ltd. The general trend of Meta Biomed Co. Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Meta Biomed Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Meta Biomed Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3,745 < 3,760 < 3,805.

The bearish price targets are: 3,210 > 2,602 > 2,468.

Tweet this
Meta Biomed Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Meta Biomed Co. Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Meta Biomed Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Meta Biomed Co. Ltd. The current macd is -30.27611955.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Meta Biomed Co. Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Meta Biomed Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Meta Biomed Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Meta Biomed Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMeta Biomed Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Meta Biomed Co. Ltd. The current adx is 17.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Meta Biomed Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Meta Biomed Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Meta Biomed Co. Ltd. The current sar is 3,252.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Meta Biomed Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Meta Biomed Co. Ltd. The current rsi is 50.48. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Meta Biomed Co. Ltd Daily Relative Strength Index (RSI) ChartMeta Biomed Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Meta Biomed Co. Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Meta Biomed Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Meta Biomed Co. Ltd Daily Stochastic Oscillator ChartMeta Biomed Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Meta Biomed Co. Ltd. The current cci is 40.90.

Meta Biomed Co. Ltd Daily Commodity Channel Index (CCI) ChartMeta Biomed Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Meta Biomed Co. Ltd. The current cmo is 7.95886027.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Meta Biomed Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartMeta Biomed Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Meta Biomed Co. Ltd. The current willr is -27.77777778.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Meta Biomed Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Meta Biomed Co. Ltd Daily Williams %R ChartMeta Biomed Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Meta Biomed Co. Ltd.

Meta Biomed Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Meta Biomed Co. Ltd. The current atr is 152.24.

Meta Biomed Co. Ltd Daily Average True Range (ATR) ChartMeta Biomed Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Meta Biomed Co. Ltd. The current obv is 143,582,985.

Meta Biomed Co. Ltd Daily On-Balance Volume (OBV) ChartMeta Biomed Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Meta Biomed Co. Ltd. The current mfi is 66.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Meta Biomed Co. Ltd Daily Money Flow Index (MFI) ChartMeta Biomed Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Meta Biomed Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Meta Biomed Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Meta Biomed Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.478
Ma 20Greater thanMa 503,575.250
Ma 50Greater thanMa 1003,799.100
Ma 100Greater thanMa 2003,965.050
OpenGreater thanClose3,580.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Meta Biomed Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Meta Biomed Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Meta Biomed Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Meta Biomed Co. Ltd

I send you an email if I find something interesting about Meta Biomed Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Meta Biomed Co. Ltd.

Receive notifications about Meta Biomed Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.